![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
Citations (87)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Pravin Shende & Mansi Waghchaure. (2019) Combined vaccines for prophylaxis of infectious conditions. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 695-704.
Read now
Read now
Nathalie Garçon & Alberta Di Pasquale. (2017) From discovery to licensure, the Adjuvant System story. Human Vaccines & Immunotherapeutics 13:1, pages 19-33.
Read now
Read now
Alba Vilajeliu, Víctor-Guillermo Sequera, Alberto L. García-Basteiro, Elisa Sicuri, Marta Aldea, César Velasco & José M. Bayas. (2016) Immunogenicity and immunization costs of adjuvanted versus non-adjuvanted hepatitis B vaccine in chronic kidney disease patients. Human Vaccines & Immunotherapeutics 12:9, pages 2317-2321.
Read now
Read now
Peng He, Yening Zou & Zhongyu Hu. (2015) Advances in aluminum hydroxide-based adjuvant research and its mechanism. Human Vaccines & Immunotherapeutics 11:2, pages 477-488.
Read now
Read now
Alicja E Grzegorzewska. (2014) Hepatitis B vaccination in chronic kidney disease patients: a call for novel vaccines. Expert Review of Vaccines 13:11, pages 1317-1326.
Read now
Read now
Jue Hou, Ying Liu, Jenny Hsi, Hongzhi Wang, Ran Tao & Yiming Shao. (2014) Cholera toxin B subunit acts as a potent systemic adjuvant for HIV-1 DNA vaccination intramuscularly in mice. Human Vaccines & Immunotherapeutics 10:5, pages 1274-1283.
Read now
Read now
Emanuele Montomoli, Simona Piccirella, Baharak Khadang, Elisa Mennitto, Roberto Camerini & Alfonso De Rosa. (2011) Current adjuvants and new perspectives in vaccine formulation. Expert Review of Vaccines 10:7, pages 1053-1061.
Read now
Read now
Franco M Buonaguro, Maria Lina Tornesello & Luigi Buonaguro. (2011) New adjuvants in evolving vaccine strategies. Expert Opinion on Biological Therapy 11:7, pages 827-832.
Read now
Read now
Catherine M. Brown, Sheila Donlon, Patrick O'Kelly, Anne Marie Casey, Cathal Collier, Peter J. Conlon & John J. Walshe. (2011) A Prospective Study of Hepatitis B Vaccination – A Comparison of Responders versus Nonresponders. Renal Failure 33:3, pages 276-279.
Read now
Read now
Nathalie Garçon & Marcelle Van Mechelen. (2011) Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems. Expert Review of Vaccines 10:4, pages 471-486.
Read now
Read now
Jiří Beran, Lenka Hobzova, Veronika Wertzova, Sherine Kuriyakose, Maarten Leyssen, Murielle Surquin & Sophie Houard. (2010) Safety and immunogenicity of an investigational adjuvanted hepatitis B vaccine (HB-AS02V) in healthy adults. Human Vaccines 6:7, pages 578-584.
Read now
Read now
Articles from other publishers (76)
Sivakumar S. Moni, Siddig Ibrahim Abdelwahab, Aamena Jabeen, Mohamed Eltaib Elmobark, Duaa Aqaili, Gassem Ghoal, Bassem Oraibi, Abdulla Mohammed Farasani, Ahmed Ali Jerah, Mahdi Mohammed A. Alnajai & Abdul Majeed Hamad Mohammad Alowayni. (2023) Advancements in Vaccine Adjuvants: The Journey from Alum to Nano Formulations. Vaccines 11:11, pages 1704.
Crossref
Crossref
Javier Castrodeza-Sanz, Iván Sanz-Muñoz & Jose M. Eiros. (2023) Adjuvants for COVID-19 Vaccines. Vaccines 11:5, pages 902.
Crossref
Crossref
Shailendra Kumar Verma, Pooja Mahajan, Nikhlesh K. Singh, Ankit Gupta, Rupesh Aggarwal, Rino Rappuoli & Atul Kumar Johri. (2023) New-age vaccine adjuvants, their development, and future perspective. Frontiers in Immunology 14.
Crossref
Crossref
John W. Ward, Nasamon Wanlapakorn, Yong Poovorawan & Daniel Shouval. 2023. Plotkin's Vaccines. Plotkin's Vaccines
389
432.e21
.
Ding-Ping Chen, Ying-Hao Wen, Wei-Tzu Lin & Fang-Ping Hsu. (2022) Association between the side effect induced by COVID-19 vaccines and the immune regulatory gene polymorphism. Frontiers in Immunology 13.
Crossref
Crossref
Yuntao Zhang, Xiaotong Zheng, Wang Sheng, Hongyang Liang, Yuxiu Zhao, Xiujuan Zhu, Rong Yang, Yadan Zhang, Xiaofei Dong, Weidong Li, Fei Pei, Ling Ding, Zhen Chang, Li Deng, Guangying Yuan, Zhaona Yang, Di Zhu, Xiaoming Yang & Hui Wang. (2022) Alum/CpG Adjuvanted Inactivated COVID-19 Vaccine with Protective Efficacy against SARS-CoV-2 and Variants. Vaccines 10:8, pages 1208.
Crossref
Crossref
Luisa Romano’ & Alessandro R. Zanetti. (2022) Hepatitis B Vaccination: A Historical Overview with a Focus on the Italian Achievements. Viruses 14:7, pages 1515.
Crossref
Crossref
Hiroyuki Shinchi, Fumikazu Komaki, Masaharu Yuki, Haruka Ohara, Naohiro Hayakawa, Masahiro Wakao, Howard B. Cottam, Tomoko Hayashi, Dennis A. Carson, Toshiro Moroishi & Yasuo Suda. (2022) Glyco-Nanoadjuvants: Impact of Linker Length for Conjugating a Synthetic Small-Molecule TLR7 Ligand to Glyco-Nanoparticles on Immunostimulatory Effects. ACS Chemical Biology 17:4, pages 957-968.
Crossref
Crossref
Jiexin Li, He Ren & Yumiao Zhang. (2022) Metal-based nano-vaccines for cancer immunotherapy. Coordination Chemistry Reviews 455, pages 214345.
Crossref
Crossref
Jing-Xing Yang, Jen-Chih Tseng, Guann-Yi Yu, Yunping Luo, Chi-Ying F. Huang, Yi-Ren Hong & Tsung-Hsien Chuang. (2022) Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases. Pharmaceutics 14:2, pages 423.
Crossref
Crossref
Wolfram H. Gerlich. (2022) Hepatitis-B-Impfstoffe – Geschichte, Erfolge, Herausforderungen und PerspektivenHepatitis B vaccines—history, achievements, challenges, and perspectives. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 65:2, pages 170-182.
Crossref
Crossref
Tetsuya Saito, Nikunj M. Shukla, Fumi Sato-Kaneko, Yukiya Sako, Tadashi Hosoya, Shiyin Yao, Fitzgerald S. Lao, Karen Messer, Minya Pu, Michael Chan, Paul J. Chu, Howard B. Cottam, Tomoko Hayashi, Dennis A. Carson & Maripat Corr. (2022) Small Molecule Calcium Channel Activator Potentiates Adjuvant Activity. ACS Chemical Biology 17:1, pages 217-229.
Crossref
Crossref
Maryam Dadar, Youcef Shahali & Naheed Mojgani. 2022. Probiotics in the Prevention and Management of Human Diseases. Probiotics in the Prevention and Management of Human Diseases
417
430
.
Nikunj M. Shukla, Michael Chan, Fitzgerald S. Lao, Paul J. Chu, Masiel Belsuzarri, Shiyin Yao, Jason Nan, Fumi Sato-Kaneko, Tetsuya Saito, Tomoko Hayashi, Maripat Corr, Dennis A. Carson & Howard B. Cottam. (2021) Structure-activity relationship studies in substituted sulfamoyl benzamidothiazoles that prolong NF-κB activation. Bioorganic & Medicinal Chemistry 43, pages 116242.
Crossref
Crossref
Mohammad Ali Savoji, Mohammad Mehdi Adibzadeh Sereshgi, Seyed Mohammad Mahdi Ghahari, Fatemeh Asgarhalvaei & Mehdi Mahdavi. (2021) Formulation of HBsAg in Montanide ISA 51VG adjuvant: Immunogenicity study and monitoring long-lived humoral immune responses. International Immunopharmacology 96, pages 107599.
Crossref
Crossref
Hui Liu, Ziyu Meng, Hesuiyuan Wang, Shuo Zhang, Zhen Huang, Xiaofang Geng, Rui Guo, Zhenzhou Wu & Zhangyong Hong. (2021) Robust Immune Responses Elicited by a Hybrid Adjuvant Based on β-Glucan Particles from Yeast for the Hepatitis B Vaccine. ACS Applied Bio Materials 4:4, pages 3614-3622.
Crossref
Crossref
Tian Yao, Zhihong Shao, Lina Wu, Shuang Dong, Linying Gao, Yuanting Wu, Xiaohong Shi, Jing Shi, Guangming Liu, Jianmin Wang, Huilin Zhao, Hongping Guo, Hongting Liu, Xiaofeng Wu, Liming Liu, Xiaohui Song, Jiangtao Zhu, Yawei Zhang, Yongliang Feng, Xiaofeng Liang & Suping Wang. (2021) Long-term persistent immunogenicity after successful standard and triple-dosed hepatitis B vaccine in hemodialysis patients: A 3-year follow-up study in China. Vaccine 39:18, pages 2537-2544.
Crossref
Crossref
Hiroyuki Shinchi, Masaharu Yuki, Takayoshi Yamauchi, Mayumi Niimura, Masahiro Wakao, Howard B. Cottam, Tomoko Hayashi, Dennis A. Carson, Toshiro Moroishi & Yasuo Suda. (2021) Glyco-Nanoadjuvants: Sugar Structures on Carriers of a Small Molecule TLR7 Ligand Affect Their Immunostimulatory Activities. ACS Applied Bio Materials 4:3, pages 2732-2741.
Crossref
Crossref
Alan H. Stokes, Kelle Franklin, Daniel E. Fisher, Lorraine M. Posobiec, Ornella Binazon, Niraj Tripathi, Michael Alan Ringenberg, Jeffrey Charlap, Mary K. Ziejewski, Vimala Vemireddi, Payal Khanna Weiss, Ritankar Majumdar, Badiaa Bouzya, Marie-Noëlle Donner, Luis-Alexander Rodriguez & Judith Baumeister. (2021) Repeated Dose Toxicity Study and Developmental and Reproductive Toxicology Studies of a Respiratory Syncytial Virus Candidate Vaccine in Rabbits and Rats. International Journal of Toxicology 40:2, pages 125-142.
Crossref
Crossref
Saghi Nooraei, Howra Bahrulolum, Zakieh Sadat Hoseini, Camellia Katalani, Abbas Hajizade, Andrew J. Easton & Gholamreza Ahmadian. (2021) Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers. Journal of Nanobiotechnology 19:1.
Crossref
Crossref
José L. Bravo-Grande, M. Asunción Blanco-González, José M. de la Torre-Robles, Marita P. Asmat-Inostrosa, Marina Fernández-Escribano, Itria Mirabella Villalobos, M. Covadonga Caso-Pita, Marina Hervella-Ordoñez, Luis M. Cañibano Cimas, José M. de la Fuente-Martín, M. Luisa Rodríguez de la Pinta, Jenry Ricardo Borda Olivas, Carmen Muñóz-Ruipérez, Miguel A. Alonso López, MT del Campo, M. Antonieta Ramírez Pérez, Ignacio Sánchez-Arcilla, Marco Marzola-Payares, Fernando Rescalvo-Santiago, Miguel de Paula-Ortiz, José M. Sánchez-Santos & Ricardo López-Pérez. (2021) Vaccination adjuvated against hepatitis B in Spanish National Healthcare System (SNS) workers typed as non-responders to conventional vaccines. Vaccine 39:3, pages 554-563.
Crossref
Crossref
John W. Ward. 2021. Hepatitis B Virus and Liver Disease. Hepatitis B Virus and Liver Disease
169
203
.
Xinyue Huang & Helen E Townley. (2020) An Assessment of Mesoporous Silica Nanoparticle Architectures as Antigen Carriers. Pharmaceutics 12:3, pages 294.
Crossref
Crossref
Ciying Qian, Xinlin Liu, Qin Xu, Zhiping Wang, Jie Chen, Tingting Li, Qingbing Zheng, Hai Yu, Ying Gu, Shaowei Li & Ningshao Xia. (2020) Recent Progress on the Versatility of Virus-Like Particles. Vaccines 8:1, pages 139.
Crossref
Crossref
Michael Chan, Fitzgerald S. Lao, Paul J. Chu, Jonathan Shpigelman, Shiyin Yao, Jason Nan, Fumi Sato-Kaneko, Vicky Li, Tomoko Hayashi, Maripat Corr, Dennis A. Carson, Howard B. Cottam & Nikunj M. Shukla. (2019) Structure–Activity Relationship Studies To Identify Affinity Probes in Bis-aryl Sulfonamides That Prolong Immune Stimuli. Journal of Medicinal Chemistry 62:21, pages 9521-9540.
Crossref
Crossref
Béatrice Laupèze, Caroline Hervé, Alberta Di Pasquale & Fernanda Tavares Da Silva. (2019) Adjuvant Systems for vaccines: 13 years of post-licensure experience in diverse populations have progressed the way adjuvanted vaccine safety is investigated and understood. Vaccine 37:38, pages 5670-5680.
Crossref
Crossref
Thibault Colombani, Thomas Haudebourg, Marion Decossas, Olivier Lambert, Grace Ada Da Silva, Frederic Altare & Bruno Pitard. (2019) Lipidic Aminoglycoside Derivatives: A New Class of Immunomodulators Inducing a Potent Innate Immune Stimulation. Advanced Science 6:16, pages 1900288.
Crossref
Crossref
L. M. Khantimirova, T. Yu. Kozlova, E. L. Postnova, V. A. Shevtsov & A. V. Rukavishnikov. (2018) Retrospective Analysis of Viral Hepatitis B Incidence in Russia from 2013 to 2017 in the Context of Preventive Vaccination. BIOpreparations. Prevention, Diagnosis, Treatment 18:4, pages 225-235.
Crossref
Crossref
Hui Liu, Zhenghu Jia, Chengmao Yang, Mei Song, Zhe Jing, Yapu Zhao, Zhenzhou Wu, Liqing Zhao, Dongsheng Wei, Zhinan Yin & Zhangyong Hong. (2018) Aluminum hydroxide colloid vaccine encapsulated in yeast shells with enhanced humoral and cellular immune responses. Biomaterials 167, pages 32-43.
Crossref
Crossref
Geert Leroux-Roels, Jakob P Cramer, Paul M Mendelman, James Sherwood, Ralf Clemens, Annelies Aerssens, Ilse De Coster, Astrid Borkowski, Frank Baehner & Pierre Van Damme. (2018) Safety and Immunogenicity of Different Formulations of Norovirus Vaccine Candidate in Healthy Adults: A Randomized, Controlled, Double-Blind Clinical Trial. The Journal of Infectious Diseases 217:4, pages 597-607.
Crossref
Crossref
Luis Martinez-Gil, Peter H. Goff & Gene S. Tan. 2018.
1
37
.
Pierre Van Damme, John W. Ward, Daniel Shouval & Alessandro Zanetti. 2018. Plotkin's Vaccines. Plotkin's Vaccines
342
374.e17
.
John W. Ward & Pierre Van Damme. 2018. Hepatitis B Virus and Liver Disease. Hepatitis B Virus and Liver Disease
91
117
.
Paratosh Prasad & John Treanor. 2018. Management of Infections in the Immunocompromised Host. Management of Infections in the Immunocompromised Host
359
374
.
Darrick Carter, Malcolm S. Duthie & Steven G. Reed. 2020. Vaccination Strategies Against Highly Variable Pathogens. Vaccination Strategies Against Highly Variable Pathogens
103
127
.
Velasco Cimica & Jose M. Galarza. (2017) Adjuvant formulations for virus-like particle (VLP) based vaccines. Clinical Immunology 183, pages 99-108.
Crossref
Crossref
Wivine Burny, Andrea Callegaro, Viviane Bechtold, Frédéric Clement, Sophie Delhaye, Laurence Fissette, Michel Janssens, Geert Leroux-Roels, Arnaud Marchant, Robert A. van den Berg, Nathalie Garçon, Robbert van der Most & Arnaud M. Didierlaurent. (2017) Different Adjuvants Induce Common Innate Pathways That Are Associated with Enhanced Adaptive Responses against a Model Antigen in Humans. Frontiers in Immunology 8.
Crossref
Crossref
Muhammad Shafique, Muhammad Hidayat Rasool & Mohsin Khurshid. (2017) Respiratory syncytial virus: an overview of infection biology and vaccination strategies. Future Virology 12:5, pages 297-313.
Crossref
Crossref
Rajni Garg, Manpreet Kaur, Ankur Saxena, Rajendra Prasad & Rakesh Bhatnagar. (2017) Alum adjuvanted rabies DNA vaccine confers 80% protection against lethal 50 LD50 rabies challenge virus standard strain. Molecular Immunology 85, pages 166-173.
Crossref
Crossref
N. Garçon & F. Tavares Da Silva. 2017. Immunopotentiators in Modern Vaccines. Immunopotentiators in Modern Vaccines
287
309
.
A.M. Didierlaurent, A. Berger, T.C. Heineman, V. Henderickx, F. Tavares Da Silva, J. Vekemans, G. Voss & N. Garçon. 2017. Immunopotentiators in Modern Vaccines. Immunopotentiators in Modern Vaccines
265
285
.
Michael Fichter, Keti Piradashvili, Anette Pietrzak-Nguyen, Leah Pretsch, Gabor Kuhn, Susanne Strand, Markus Knuf, Fred Zepp, Frederik R. Wurm, Volker Mailänder, Katharina Landfester & Stephan Gehring. (2016) Polymeric hepatitis C virus non-structural protein 5A nanocapsules induce intrahepatic antigen-specific immune responses. Biomaterials 108, pages 1-12.
Crossref
Crossref
Steven G Reed, Fan-Chi Hsu, Darrick Carter & Mark T Orr. (2016) The science of vaccine adjuvants: advances in TLR4 ligand adjuvants. Current Opinion in Immunology 41, pages 85-90.
Crossref
Crossref
Karen A.O. Martins, Christopher L. Cooper, Sabrina M. Stronsky, Sarah L.W. Norris, Steven A. Kwilas, Jesse T. Steffens, Jacqueline G. Benko, Sean A. van Tongeren & Sina Bavari. (2016) Adjuvant-enhanced CD4 T Cell Responses are Critical to Durable Vaccine Immunity. EBioMedicine 3, pages 67-78.
Crossref
Crossref
Sujin LeeMinh Trang Nguyen. (2015) Recent Advances of Vaccine Adjuvants for Infectious Diseases. Immune Network 15:2, pages 51.
Crossref
Crossref
Shraddha S. Rane, Jaimy Mariam Sultana Javad & Robert C. Rees. 2015. Cancer Immunology. Cancer Immunology
55
71
.
Cac T. Bui, Lisa M. Shollenberger, Yvonne Paterson & Donald A. Harn. (2014) Schistosoma mansoni Soluble Egg Antigens Enhance Listeria monocytogenes Vector HIV-1 Vaccine Induction of Cytotoxic T Cells. Clinical and Vaccine Immunology 21:9, pages 1232-1239.
Crossref
Crossref
Alexander Batista-Duharte, Miriam Lastre & Oliver Pérez. (2014) Adyuvantes inmunológicos. Determinantes en el balance eficacia-toxicidad de las vacunas contemporáneas. Enfermedades Infecciosas y Microbiología Clínica 32:2, pages 106-114.
Crossref
Crossref
xxx. (2013) Safety and immunogenicity of a glycoprotein D genital herpes vaccine in healthy girls 10–17 years of age: Results from a randomised, controlled, double-blind trial. Vaccine 31:51, pages 6136-6143.
Crossref
Crossref
Ritu Soni, Bruce Horowitz & Mark Unruh. (2013) Immunization in End-Stage Renal Disease: Opportunity to Improve Outcomes. Seminars in Dialysis 26:4, pages 416-426.
Crossref
Crossref
Fernanda Tavares, Brigitte Cheuvart, Thomas Heineman, Felix Arellano & Gary Dubin. (2013) Meta-analysis of pregnancy outcomes in pooled randomized trials on a prophylactic adjuvanted glycoprotein D subunit herpes simplex virus vaccine. Vaccine 31:13, pages 1759-1764.
Crossref
Crossref
Ashwini Tayade & Venkatasubramanian Ramasubramanian. (2013) Vaccination in CKD patients. Apollo Medicine 10:1, pages 29-35.
Crossref
Crossref
Elena Mata, Aiala Salvador, Manoli Igartua, Rosa María Hernández & José Luis Pedraz. (2013) Malaria Vaccine Adjuvants: Latest Update and Challenges in Preclinical and Clinical Research. BioMed Research International 2013, pages 1-19.
Crossref
Crossref
Pierre Van Damme, John Ward, Daniel Shouval, Steven Wiersma & Alessandro Zanetti. 2013. Vaccines. Vaccines
205
234
.
James H. Conway & Roman Aydiko Ayele. 2013. Vaccinophobia and Vaccine Controversies of the 21st Century. Vaccinophobia and Vaccine Controversies of the 21st Century
213
233
.
Jennifer A Whitaker, Nadine G Rouphael, Srilatha Edupuganti, Lilin Lai & Mark J Mulligan. (2012) Strategies to increase responsiveness to hepatitis B vaccination in adults with HIV-1. The Lancet Infectious Diseases 12:12, pages 966-976.
Crossref
Crossref
Christian J.P.A. Hoebe, Angelique P.A. Vermeiren & Nicole H.T.M. Dukers-Muijrers. (2012) Revaccination with Fendrix® or HBVaxPro® results in better response rates than does revaccination with three doses of Engerix-B® in previous non-responders. Vaccine 30:48, pages 6734-6737.
Crossref
Crossref
Minling Hu, Zhenyi Su, Yanxia Yin, Jing Li & Qun Wei. (2012) Calcineurin B subunit triggers innate immunity and acts as a novel Engerix-B® HBV vaccine adjuvant. Vaccine 30:32, pages 4719-4727.
Crossref
Crossref
Antu K. Dey, Brian Burke, Yide Sun, Karin Hartog, Jonathan L. Heeney, David Montefiori, Indresh K. Srivastava & Susan W. Barnett. (2012) Use of a polyanionic carbomer, Carbopol971P, in combination with MF59, improves antibody responses to HIV-1 envelope glycoprotein. Vaccine 30:17, pages 2749-2759.
Crossref
Crossref
Scott A. Halperin, Brian Ward, Curtis Cooper, Gerald Predy, Francisco Diaz-Mitoma, Marc Dionne, Joanne Embree, Allison McGeer, Paul Zickler, Karl-Heinz Moltz, René Martz, Ingo Meyer, Shelly McNeil, Joanne M. Langley, Eduardo Martins, William L. Heyward & J. Tyler Martin. (2012) Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18–55 years of age. Vaccine 30:15, pages 2556-2563.
Crossref
Crossref
Nathalie Garçon, Sandra Morel, Arnaud Didierlaurent, Dominique Descamps, Martine Wettendorff & Marcelle Van Mechelen. (2011) Development of an AS04-Adjuvanted HPV Vaccine with the Adjuvant System Approach. BioDrugs 25:4, pages 217-226.
Crossref
Crossref
Åsa Schiött, Kristina Larsson, Søren Manniche, Suzanne Kalliomäki, Annette Vinther Heydenreich, Kristian Dalsgaard & Nikolai Kirkby. (2011) Posintro™-HBsAg, a modified ISCOM including HBsAg, induces strong cellular and humoral responses. International Journal of Pharmaceutics 414:1-2, pages 312-320.
Crossref
Crossref
Nathalie Garçon, Lawrence Segal, Fernanda Tavares & Marcelle Van Mechelen. (2011) The safety evaluation of adjuvants during vaccine development: The AS04 experience. Vaccine 29:27, pages 4453-4459.
Crossref
Crossref
Christian L. Tielemans, Jiri Vlasak, Dezider Kosa, Jean-Marie Billiouw, Gert A. Verpooten, Ilona Mezei, Miroslav Ryba, Patrick C. Peeters, Olivier Mat, Michel Y. Jadoul, Vladimir Polakovic, Michel Dhaene, Serge Treille, Sherine O. Kuriyakose, Maarten Leyssen, Sophie A. Houard & Murielle Surquin. (2011) Immunogenicity and safety of an investigational AS02v-adjuvanted hepatitis B vaccine in patients with renal insufficiency who failed to respond or to maintain antibody levels after prior vaccination: Results of two open, randomized, comparative trials. Vaccine 29:6, pages 1159-1166.
Crossref
Crossref
Vincent C. Emery, Hermann Einsele, Sowsan Atabani & Tanzina Haque. (2011) Immunotherapy and Vaccination After Transplant: The Present, the Future. Hematology/Oncology Clinics of North America 25:1, pages 215-229.
Crossref
Crossref
Andreas Wadle, Axel Mischo, Sabine Strahl, Hiroyoshi Nishikawa, Gerhard Held, Frank Neumann, Beate Wullner, Eliane Fischer, Sascha Kleber, Julia Karbach, Elke Jager, Hiroshi Shiku, Kunle Odunsi, Protul A. Shrikant, Alexander Knuth, Vincenzo Cerundolo & Christoph Renner. (2010) NY-ESO-1 protein glycosylated by yeast induces enhanced immune responses. Yeast 27:11, pages 919-931.
Crossref
Crossref
G Brook, V Soriano & C Bergin. (2010) European guideline for the management of hepatitis B and C virus infections, 2010. International Journal of STD & AIDS 21:10, pages 669-678.
Crossref
Crossref
Robert L. Coffman, Alan Sher & Robert A. Seder. (2010) Vaccine Adjuvants: Putting Innate Immunity to Work. Immunity 33:4, pages 492-503.
Crossref
Crossref
Vincent C. Emery, Hermann Einsele, Sowsan Atabani & Tanzina Haque. (2010) Immunotherapy and Vaccination After Transplant: The Present, the Future. Infectious Disease Clinics of North America 24:2, pages 515-529.
Crossref
Crossref
Katherine A. Barraclough & E. Geoffrey Playford. (2010) Hepatitis B virus infection in hemodialysis populations: progress toward prevention. Kidney International 77:3, pages 177-180.
Crossref
Crossref
Murielle Surquin, Christian L. Tielemans, Imre Kulcsár, Miroslav Ryba, Péter Vörös, Olivier Mat, Serge Treille, Michel Dhaene, Jean-Claude Stolear, Sherine O. Kuriyakose, Maarten X. Leyssen & Sophie A. Houard. (2010) Rapid, enhanced, and persistent protection of patients with renal insufficiency by AS02V-adjuvanted hepatitis B vaccine. Kidney International 77:3, pages 247-255.
Crossref
Crossref
Nathalie Garçon. 2010. Vaccine Adjuvants. Vaccine Adjuvants
15
27
.
Lluís Castells. (2009) Vacuna contra el virus de la hepatitis B y enfermedad inflamatoria intestinal. Medicina Clínica 132:9, pages 348-350.
Crossref
Crossref
Jennifer Cohn & Emily A Blumberg. (2008) Immunizations for renal transplant candidates and recipients. Nature Clinical Practice Nephrology 5:1, pages 46-53.
Crossref
Crossref
Alessandro R. Zanetti, Pierre Van Damme & Daniel Shouval. (2008) The global impact of vaccination against hepatitis B: A historical overview. Vaccine 26:49, pages 6266-6273.
Crossref
Crossref
. (2008) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 17:8, pages i-xvi.
Crossref
Crossref